No abstract available
Keywords:
B lymphocytes; Immunotherapy; Large granular lymphocytic leukemia; Multiple myeloma; T lymphocytes.
MeSH terms
-
Aged
-
Aged, 80 and over
-
Anemia / etiology
-
Angiogenesis Inhibitors / administration & dosage
-
Angiogenesis Inhibitors / therapeutic use
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Boronic Acids / administration & dosage
-
Boronic Acids / therapeutic use
-
Bortezomib
-
Causality
-
Cladribine / therapeutic use
-
Combined Modality Therapy
-
Cyclophosphamide / therapeutic use
-
Disease Progression
-
Female
-
Humans
-
Lenalidomide
-
Leukemia, Large Granular Lymphocytic / blood
-
Leukemia, Large Granular Lymphocytic / complications*
-
Leukemia, Large Granular Lymphocytic / drug therapy
-
Leukemia, Large Granular Lymphocytic / pathology
-
Male
-
Melphalan / administration & dosage
-
Methotrexate / therapeutic use
-
Middle Aged
-
Multiple Myeloma / drug therapy
-
Multiple Myeloma / etiology
-
Multiple Myeloma / therapy
-
Neutropenia / etiology
-
Paraproteinemias / complications*
-
Paraproteinemias / drug therapy
-
Paraproteinemias / pathology
-
Peripheral Blood Stem Cell Transplantation
-
Prednisone / administration & dosage
-
Protease Inhibitors / administration & dosage
-
Protease Inhibitors / therapeutic use
-
Pyrazines / administration & dosage
-
Pyrazines / therapeutic use
-
Registries
-
Retrospective Studies
-
Thalidomide / administration & dosage
-
Thalidomide / analogs & derivatives
-
Thalidomide / therapeutic use
Substances
-
Angiogenesis Inhibitors
-
Boronic Acids
-
Protease Inhibitors
-
Pyrazines
-
Cladribine
-
Thalidomide
-
Bortezomib
-
Cyclophosphamide
-
Lenalidomide
-
Melphalan
-
Prednisone
-
Methotrexate